Toll-like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation?
- PMID: 19335065
- DOI: 10.1517/14728220902794939
Toll-like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation?
Abstract
Background: There is increasing evidence that Toll-like receptors (TLRs) sense host tissue damage by engaging with endogenous ligands. TLRs are considered to be involved in many primarily non-immune-related diseases. Hepatic ischemia reperfusion injury (IRI) represents one of these disorders.
Objective: To present the latest findings supporting the involvement of TLRs in liver IRI and to explore their role as potential targets for therapeutic intervention.
Methods: A review of the literature summarizing the latest advances in TLR signaling, the role of TLRs in each hepatic cell population and the involvement of TLRs in the pathophysiology of hepatic IRI. The potential role of TLR-targeting treatment strategies in liver IRI is discussed.
Conclusions: Recent experimental evidence suggests that TLR activation on Kupffer cells provides the triggering signal for pro-inflammatory responses that lead to liver IRI. Modulating TLR signaling could have a beneficial effect in patients with liver IRI.
Similar articles
-
Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury?Expert Opin Ther Targets. 2010 Aug;14(8):839-53. doi: 10.1517/14728222.2010.500286. Expert Opin Ther Targets. 2010. PMID: 20568914 Review.
-
Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells.Biomed Pharmacother. 2017 May;89:1392-1400. doi: 10.1016/j.biopha.2017.03.022. Epub 2017 Mar 19. Biomed Pharmacother. 2017. PMID: 28320107
-
Role of toll-like receptors in liver transplantation.Liver Transpl. 2014 Mar;20(3):270-80. doi: 10.1002/lt.23793. Epub 2014 Feb 3. Liver Transpl. 2014. PMID: 24243591 Review.
-
Toll-like receptors in acute liver injury and regeneration.Int Immunopharmacol. 2011 Oct;11(10):1433-41. doi: 10.1016/j.intimp.2011.04.023. Epub 2011 May 19. Int Immunopharmacol. 2011. PMID: 21601014 Review.
-
Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.J Immunol. 2004 Dec 15;173(12):7115-9. doi: 10.4049/jimmunol.173.12.7115. J Immunol. 2004. PMID: 15585830
Cited by
-
Advanced omics approaches in liver transplant settings: current applications and future prospectives.Front Immunol. 2025 Jul 11;16:1564248. doi: 10.3389/fimmu.2025.1564248. eCollection 2025. Front Immunol. 2025. PMID: 40718477 Free PMC article. Review.
-
Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.World J Gastroenterol. 2015 Mar 14;21(10):2937-48. doi: 10.3748/wjg.v21.i10.2937. World J Gastroenterol. 2015. PMID: 25780291 Free PMC article.
-
TNFα-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response.Oxid Med Cell Longev. 2019 May 12;2019:2301903. doi: 10.1155/2019/2301903. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31214277 Free PMC article.
-
Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.Curr Signal Transduct Ther. 2011;6(3):428-440. doi: 10.2174/157436211797483930. Curr Signal Transduct Ther. 2011. PMID: 28373830 Free PMC article.
-
Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology.HPB Surg. 2012;2012:176723. doi: 10.1155/2012/176723. Epub 2012 May 30. HPB Surg. 2012. PMID: 22693364 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
